{
  "metadata": {
    "case_id": 64,
    "model": "Gemini-3-Pro",
    "timestamp": "2025-11-29T18:00:04.234983",
    "total_alignments": 3,
    "target_section": "protocolSection",
    "ground_truth_path": "/{YOURPATH}/samples/CTG/protocolSection/1_100/64_NCT04234984.json",
    "prediction_path": "/{YOURPATH}/restructured_outputs_protocol/Gemini-3-Pro/64_Gemini-3-Pro.json",
    "shard_range": "1_100"
  },
  "alignments": [
    {
      "field_path": "protocolSection.armsInterventionsModule.armGroups",
      "algorithm": "hungarian",
      "ref_count": 1,
      "pred_count": 2,
      "similarity_matrix": [
        [
          0.86,
          0.86
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 0,
          "score": 0.86,
          "status": "matched",
          "ref_item": {
            "label": "Conventional radiofrequency (RF) treatment",
            "description": "All patients with chronic knee pain who qualify for a conventional RF treatment of the genicular nerves"
          },
          "pred_item": {
            "label": "PPSP Group",
            "type": "EXPERIMENTAL",
            "description": "Patients diagnosed with persistent post-surgical pain (PPSP), primarily after total knee arthroplasty (TKA), suffering from chronic anterior knee pain.",
            "interventionNames": [
              "Procedure: Ultrasound-guided conventional radiofrequency (RF) treatment of the genicular nerves"
            ]
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.outcomesModule.primaryOutcomes",
      "algorithm": "hungarian",
      "ref_count": 1,
      "pred_count": 1,
      "similarity_matrix": [
        [
          0.99
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 0,
          "score": 0.99,
          "status": "matched",
          "ref_item": {
            "measure": "The Number of Patients Reaching Treatment Succes at 6 Weeks Defined as Global Perceived Effect (GPE) of ≥ 50% Compared to Baseline.",
            "description": "Treatment success is defined as a global perceived effect (GPE) of at least 50% at measurement time point compared to baseline.\n\nGlobal perceived effect (GPE) scales are used as an overall outcome measure for patients with pain, as they may cover additional aspects to pain relief and physical function that are important to the individual. Patients are asked to response on the question of how the treatment influenced the pain symptoms. The patients were asked to expres their answer in percentage where 0 % ( no improvement) to 100 (total improvement, the symptoms are gone).",
            "timeFrame": "6 weeks after treatment"
          },
          "pred_item": {
            "measure": "Proportion of patients with treatment success",
            "description": "Treatment success defined as a Global Perceived Effect (GPE) of ≥50% compared to baseline.",
            "timeFrame": "Week 6"
          }
        }
      ]
    },
    {
      "field_path": "protocolSection.outcomesModule.secondaryOutcomes",
      "algorithm": "hungarian",
      "ref_count": 8,
      "pred_count": 7,
      "similarity_matrix": [
        [
          0.7,
          0.92,
          0.1,
          0.6,
          0.4,
          0.1,
          0.05
        ],
        [
          0.3,
          0.78,
          0.15,
          0.72,
          0.4,
          0.2,
          0.1
        ],
        [
          0.78,
          0.25,
          0.82,
          0.2,
          0.08,
          0.08,
          0.05
        ],
        [
          0.2,
          0.18,
          0.08,
          0.2,
          0.94,
          0.52,
          0.2
        ],
        [
          0.2,
          0.2,
          0.21,
          0.2,
          0.9,
          0.2,
          0.13
        ],
        [
          0.95,
          0.6,
          0.18,
          0.55,
          0.12,
          0.08,
          0.12
        ],
        [
          0.18,
          0.08,
          0.18,
          0.11,
          0.2,
          0.22,
          0.88
        ],
        [
          0.18,
          0.12,
          0.05,
          0.08,
          0.15,
          0.2,
          0.86
        ]
      ],
      "matched_pairs": [
        {
          "ref_idx": 0,
          "pred_idx": 1,
          "score": 0.92,
          "status": "matched",
          "ref_item": {
            "measure": "The Number of Participants With NRS Reduction ≥50% Compared to Baseline",
            "description": "The numeric rating scale (NRS) is used to assess pain intensity varying from 0 (no pain) to 10 (intense pain). This scale was retrieved retrospectively out of the patient file.\n\nNRS reduction ≥50% is calculated using the NRS at 6 weeks compared to the NRS at baseline.",
            "timeFrame": "6 weeks after treatment"
          },
          "pred_item": {
            "measure": "Numeric Rating Scale (NRS) reduction",
            "description": "Proportion of patients with NRS reduction ≥50% compared to baseline.",
            "timeFrame": "Week 6 and at the second time point"
          }
        },
        {
          "ref_idx": 1,
          "pred_idx": 3,
          "score": 0.72,
          "status": "matched",
          "ref_item": {
            "measure": "The Patient's NRS",
            "description": "The numeric rating scale (NRS) is used to assess pain intensity varying from 0 (no pain) to 10 (intense pain). This scale will be asked telephonically to the patient.",
            "timeFrame": "after retrieval of informed consent, ranging from 6 weeks to 2.5 years after the procedure"
          },
          "pred_item": {
            "measure": "Long-term treatment effect",
            "description": "Defined as the period with pain reduction.",
            "timeFrame": "Through follow-up period (up to 27 months)"
          }
        },
        {
          "ref_idx": 2,
          "pred_idx": 2,
          "score": 0.82,
          "status": "matched",
          "ref_item": {
            "measure": "The Number of Patients With Subjective Increase in Physical Functioning at the Second Time Point",
            "description": "The question 'Do you experience at the moment functional improvement in comparison with before the treatment?' is asked telephonically to the patient. The possible answers are 'no increase in physical functioning' and ' yes, there was an increase in physical funcitoning'. An increase in physical functioning is the best outcome.",
            "timeFrame": "after retrieval of informed consent, ranging from 6 weeks to 2.5 years after the procedure"
          },
          "pred_item": {
            "measure": "Subjective physical functioning",
            "description": "Subjective functional outcome assessed via questionnaire.",
            "timeFrame": "Second time point"
          }
        },
        {
          "ref_idx": 3,
          "pred_idx": 5,
          "score": 0.52,
          "status": "matched",
          "ref_item": {
            "measure": "The Number of Pariticipants Using Strong Opioids",
            "description": "The change in use of strong opioids is retrieved retrospectively out of the patient file. The answer to the use of strong opioids is yes or no. No use of strong opioids is a better outcome.",
            "timeFrame": "6 weeks after treatment"
          },
          "pred_item": {
            "measure": "Rescue interventions",
            "description": "The need for rescue therapy.",
            "timeFrame": "Through follow-up period"
          }
        },
        {
          "ref_idx": 4,
          "pred_idx": 4,
          "score": 0.9,
          "status": "matched",
          "ref_item": {
            "measure": "Strong Opioid Use at the Second Time Point",
            "description": "The change in use of strong opioids is asked telephonically to the patient.",
            "timeFrame": "after retrieval of informed consent, ranging from 6 weeks to 2.5 years after the procedure"
          },
          "pred_item": {
            "measure": "Use of strong opioids",
            "description": "Evaluation of the change in use of strong opioids.",
            "timeFrame": "Week 6 and at the second time point"
          }
        },
        {
          "ref_idx": 5,
          "pred_idx": 0,
          "score": 0.95,
          "status": "matched",
          "ref_item": {
            "measure": "The Number of Participants Reaching Treatment Success After Retrieval of the Informed Consent Defined as GPE of ≥ 50% Compared to Baseline.",
            "description": "Treatment success is defined as a global perceived effect (GPE) of at least 50% at measurement time point compared to baseline.\n\nGlobal perceived effect (GPE) scales are used as an overall outcome measure for patients with pain, as they may cover additional aspects to pain relief and physical function that are important to the individual. Patients are asked to response on the question of how the treatment influenced the pain symptoms. The patients were asked to expres their answer in percentage where 0 % ( no improvement) to 100 (total improvement, the symptoms are gone).",
            "timeFrame": "after retrieval of informed consent, ranging from 6 weeks to 2.5 years after the procedure"
          },
          "pred_item": {
            "measure": "Proportion of patients with treatment success at follow-up",
            "description": "Treatment success defined as a GPE of ≥50% compared to baseline.",
            "timeFrame": "Second time point (variable follow-up, mean 17 months)"
          }
        },
        {
          "ref_idx": 6,
          "pred_idx": 6,
          "score": 0.88,
          "status": "matched",
          "ref_item": {
            "measure": "Number of Participants With Post-treatment Complications",
            "description": "Adverse events related to the conventional radiofrequency therapy will be assessed. This will be assessed retrospectively in the patient file according to the standard of care consultation at 6 weeks after treatment.",
            "timeFrame": "6 weeks after treatment."
          },
          "pred_item": {
            "measure": "Adverse events",
            "description": "Number, type, and severity of adverse events.",
            "timeFrame": "Week 6 and at the second time point"
          }
        },
        {
          "ref_idx": 7,
          "pred_idx": null,
          "score": null,
          "status": "padded",
          "ref_item": {
            "measure": "Number of Participants With Post-treatment Complications",
            "description": "Adverse events related to the conventional radiofrequency therapy will be assessed telephonically",
            "timeFrame": "after retrieval of informed consent, ranging from 6 weeks to 2.5 years after the procedure"
          },
          "pred_item": null
        }
      ]
    }
  ]
}